Ikarian Capital’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,428
| Closed | -$6.27K | – | 113 |
|
|
2024
Q1 | $6.27K | Hold |
4,428
| – | – | ﹤0.01% | 81 |
|
|
2023
Q4 | $6.53K | Hold |
4,428
| – | – | ﹤0.01% | 78 |
|
|
2023
Q3 | $6.22K | Sell |
4,428
-16,083
| -78% | -$22.6K | ﹤0.01% | 79 |
|
|
2023
Q2 | $29.8K | Hold |
20,511
| – | – | ﹤0.01% | 79 |
|
|
2023
Q1 | $476K | Hold |
20,511
| – | – | 0.11% | 71 |
|
|
2022
Q4 | $151K | Hold |
20,511
| – | – | 0.04% | 57 |
|
|
2022
Q3 | $146K | Sell |
20,511
-3,758
| -15% | -$26.8K | 0.03% | 57 |
|
|
2022
Q2 | $185K | Hold |
24,269
| – | – | 0.03% | 83 |
|
|
2022
Q1 | $192K | Buy |
24,269
+1,335
| +6% | +$10.6K | 0.03% | 129 |
|
|
2021
Q4 | $187K | Sell |
22,934
-12,500
| -35% | -$102K | 0.03% | 127 |
|
|
2021
Q3 | $288K | Buy |
35,434
+4,821
| +16% | +$39.2K | 0.02% | 133 |
|
|
2021
Q2 | $248K | Hold |
30,613
| – | – | 0.02% | 147 |
|
|
2021
Q1 | $243K | Sell |
30,613
-19,548
| -39% | -$155K | 0.01% | 157 |
|
|
2020
Q4 | $405K | Buy |
+50,161
| New | +$405K | 0.02% | 108 |
|